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Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a neglected tropical disease fre-
quently leading to permanent disabilities. The ulcers are treated with rifampicin and strepto-
mycin, wound care and, if necessary surgical intervention. Professionals have exclusively
shaped the research agenda concerning management and control, while patients’ perspec-
tive on priorities and preferences have not explicitly been explored or addressed.
Methodology/Principal findings
To get insight into patient perception of the management and control of Buruli ulcer a mixed
methods research design was applied with a questionnaire and focus group discussions
among former BU patients. Data collection was obtained in collaboration with a local team of
native speakers in Ghana. A questionnaire was completed by 60 former patients and four
focus group discussions were conducted with eight participants per group. Former patients
positively evaluated both the effectiveness of the treatment and the financial contribution
received for the travel costs to the hospitals. Pain experienced during treatment procedures,
in particular wound care and the streptomycin injections, and the side-effects of the treat-
ment were negatively evaluated. Former patients considered the development of preventive
measures and knowledge on the transmission as priorities. Additionally, former patients
asked for improved accessibility of health services, counselling and economic support.
Conclusions
These findings can be used to improve clinical management and to guide the international
research agenda.
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Author Summary
Buruli ulcer (BU) is a skin and soft tissue infection possibly leading to deformities and
long term consequences with severe impact on patients’ lives. It is one of the neglected
tropical diseases. The current research agenda is created solely by health professionals,
whereas patients might indicate different priorities. Therefore we conducted qualitative
research on former patients’ experience with the BU management and on the priorities
for the research agenda as envisaged by patients. We found that the preferences of former
patients appeared generally in agreement with the international research agenda. Addi-
tionally, they indicated that additional preventive measures, better accessibility to care
and pain management were important subjects for them. More counselling and social
support in the form of community-based rehabilitation were expected to contribute in
dealing with the impact of the disease and to enlarge a public platform for support. For
clinical management we found that more information on the disease appears necessary,
since former patients indicate they did not know much about the course of treatment and
expected side-effects. Involving patients can improve BU management and its research
agenda.
Introduction
Buruli ulcer (BU) is a devastating skin and soft tissue infection prevalent in several tropical
and subtropical endemic areas worldwide, with the highest prevalence in West Africa [1,2].
BU is caused by infection with Mycobacterium ulcerans (M. ulcerans). It is the third most com-
mon mycobacterial disease in immunocompetent persons [3,4]. In early disease stages BU
presents as a painless nodule, plaque or oedema. Without treatment these lesions go on to
ulcerate presenting with characteristic undermined edges. The lesions are divided in three cat-
egories; Category I: a single lesion <5cm in diameter. Category II: a single lesion 5-15cm in
diameter. Category III: single lesion >15cm in diameter, multiple lesions, lesions at critical
sites such as eye, breasts, genitalia and osteomyelitis [5]. Drug treatment for BU consists of a
combination of antibiotics given for an eight weeks period. The current World Health Organi-
zation (WHO)-recommended regimen is rifampicin (10 mg/kg once daily, oral tablet) com-
bined with streptomycin (15mg/kg once daily, intramuscular injection). Wound care is
performed three times a week to daily depending on the severity of the wound. Almost 30% of
patients indicate pain during the wound care procedure [6]. Physiotherapy is required to pro-
mote healing of the wounds and to prevent disabilities [7]. Over 90% of the early detected, lim-
ited cases (<10cm diameter) can be treated with antibiotics alone and have a good quality of
life in long-term follow-up [8,9]. Health seeking behaviour among BU patients is complex
[10–12]; If BU patients delay in seeking medical care, they run an increased chance to develop
complications [13–15]. Patients who present with larger lesions are more at risk of developing
contractures, functional limitations, and social participation restrictions [15,16]. Surgical treat-
ment, including skin grafting may be necessary in patients with complicated lesions or without
satisfying response to antimicrobial treatment.
The pathological mechanisms, tissue necrosis, immune suppression as well as the painless-
ness of the ulcers, are mediated by the toxin mycolactone produced by M. ulcerans [2,17].
Although M. ulcerans is believed to be acquired from environmental sources in endemic
areas, the exact mode of transmission is currently incompletely understood. Risk factors iden-
tified that increase susceptibility for BU include being aged below 15 years or over 49 years,
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poor hygiene of existing wounds, living close to stagnant water, insect bites, the water sources
used and the activities near them [18,19].
The current research priorities as stated by WHO are the mode of transmission, develop-
ment of methods for early diagnosis, drug treatment and new treatment modalities, vaccines,
cultural and social-economic studies and lastly, incidence, prevalence and mapping of BU
[20]. Patient’s perspectives on a disease may however lead to different priorities compared to
researcher’s priorities [21–23].
This study questions former BU patients about their experiences and the congruent priori-
ties for research and interventions to improve management of BU.
Methods
Study area
The study was conducted in two endemic rural areas in Ghana, near Agogo Presbyterian Hos-
pital and Nkawie/Toase Governmental hospital in Agogo and Nkawie respectively. Both hospi-
tals are important BU treatment centers in their areas. In 2015, the hospital in Agogo treated
17% of the new BU patients registered nationally.
Study design
A mixed method design was used consisting of questionnaires with open-ended and multi-
ple choice questions and focus group discussions. Between June and November 2012 the
questionnaires were administered. Thereafter between August and November 2014 focus
group discussions were organized in order to further discuss the topics identified, combined
with patients’ experiences, perceptions and suggestions for improvements and future
research. Four focus group discussions were held; the number of focus group discussions
chosen was based on reported evidence that 70–80% of relevant topics were identified after
four discussions [24].
Participants
Former BU patients residing in the catchment area of Agogo and Nkawie were eligible for par-
ticipation. Participants were at least 16 years old, healed from a small BU lesion (Category I or
II) within a year after start of treatment. Community volunteers were instrumental in localising
them on their last known address in hospital administration. The questionnaires were adminis-
tered to 71 participants. These participants in the BURULICO trial between 2006 and 2009
could be retrieved for follow-up visits on long-term consequences as described in Klis et al [25].
The focus group discussions were conducted with eight randomly selected participants per
group, selected by purposive sampling based on hospital records. The aim was to obtain a het-
erogeneous group concerning age, profession and education to encourage the discussion. One
female group and one male group discussion were conducted in each area, so in total 16
females and 16 males participated in the discussion. Male and female groups were chosen due
to existing gender inequalities in traditional Ghanaian communities [26,27]. Therefore it was
expected that participants would be more open and feel more at ease to express their opinions
and experiences in homogenous groups [28,29].
Data collection
Due to a high rate of illiteracy among the participants, all questionnaires were administered
orally in their native language. Three trained local hospital staff members administered the
questionnaires in a quiet private place.
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The focus group discussions were performed by a local team organised according to the
principles specified on organising focus group discussions in low-income countries [24]. Pre-
liminary testing, training of the moderator and note taker, and a pilot study with hospital staff
were completed before data collection. The participants were given a reimbursement for their
transportation and participation when the groups were finished. The recordings of the focus
group discussions were then translated and transcribed by the note taker, who supplemented
the recordings with his notes made during the meetings. The translation and transcription
were checked by a second member of the research team.
Data analysis
Qualitative analysis was performed on the final English transcripts using open coding and
axial coding. During the open coding, the English transcripts were read carefully and codes
were assigned, which was done individually by two people (AV and RW). The initial codebook
was developed based on the open coding of two interviews. Thereafter, the two separate code-
books were discussed and combined in regular meetings. In case of disagreement other
researchers (YS and JDZ) were consulted in order to reach consensus. Throughout data collec-
tion the codebook was adapted based on new codes that emerged from the data. After the
open coding, the various codes were subjected to a process of axial coding in order to develop
categories and identify connections.
Ethics
The study protocol was approved by the Committee on Human Research, Publication, and
Ethics of the Kwame Nkrumah University of Science and Technology and the Komfo Anokye
Teaching Hospital, Kumasi (reference number CHRPE/RC/158/14).
Informed consent or assent for the questionnaires and all focus group discussions was
explained and obtained and the forms were signed by signature or thumbprint by participants
and by parents or legal representatives in participants <18 years.
Results
Participant characteristics
All participants approached for the questionnaires were willing to participate. Of the 71
administered questionnaires, 11 were incomplete and 60 were included in analysis.
The majority of these participants were females (N = 42; 70%). The age of the participants
ranged between 16 and 77 years, with a median of 23 years (IQR (25–75%) 18–31). All these
participants had lesions< 10 cm in diameter.
One of the 33 persons approached for the focus group discussion refused due to work and
time-related issues. The age distribution was from 18 till 73. Only 3 former patients in this
group had had category 3 lesions.
Findings of the questionnaires concerning experiences of the former patients
The results of the questionnaire on the multiple choice questions exploring which aspects of
suffering from BU was important, with a Likert scale reflecting the degree of their dissatisfac-
tion, are shown in Fig 1. 49 former patients (82%) reported not to have disliked the treatment
aspects they were interviewed about in the open questions, but in the multiple choice ques-
tions, only 4 (6.7%) indicated no dislike for any of the aspects mentioned. More than 50% of
the participants disliked the pain they experienced during treatment. Other striking results
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include that 60% of participants disliked the uncertainty about how they contracted the disease.
For 22% of these participants, this was their only dislike.
Furthermore, during the open questions, 27 participants(45%) didn’t mention anything. 15
participants (25%) found it bothersome that they ran into trouble with work or school. Being
bothered by side-effects, pain, stigma and having to walk a long distance to receive treatment
were also mentioned. Moreover, when asked what they disliked, 11 participants (18%) men-
tioned injections, pills, dressings and punch biopsies. When asked what they liked, a third of
the participants reported to appreciate the small incentive they received. The effectiveness of
treatment was mentioned as well; 13 participants (22%) enjoyed the way they were welcomed
and treated in the hospital. Additionally, singular aspects of treatment were mentioned as well
as their effectiveness. We did not explore why these things were considered positive.
Findings of the focus group discussions concerning experiences and
suggestions of the former patients
Information received on the disease and treatment. Almost half of the participants
stated they were not given enough information. Participants indicated that they did not know
where to turn to when they developed symptoms of BU. Most of the participants were directed,
either by community volunteers or other people who knew about it, or had had the disease
before. A few mentioned that they received previous education and information on BU in the
community or that they had heard about the disease from others.
Opinions about wound dressings. The opinions on dressings were very unanimous.
Dressings were found to be very painful but very effective. ‘‘It was very effective, because I real-
ized it was getting better and better each day.” A lot of examples and reasons for pain during
changing of dressings were mentioned. ‘‘The dressing of the wound is very painful, especially
when they are removing the previous gauze on the wound” No option for improvement or
changes to reduce the pain during dressings were given.
Fig 1. summary of multiple-choice questions analysis–scores represent Likert scales of increasing discomfort with
treatment aspects.
doi:10.1371/journal.pntd.0005261.g001
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Experiences of treatment. The experiences of treatment were very broad. Considering
the effectivity, the participants did not mind the eight weeks duration of the treatment in general.
Women compared to men mentioned more problems and negative experiences with going to
the health centre. ‘‘I was walking long distance everyday”. In addition, many participants men-
tioned severe side-effects and problems with the injections and/or tablets. The injection was
mainly found to be painful, additionally some were scared of the needles or mentioned other
aspects. ‘‘I also preferred the tablet over the injection, because after receiving the injection, I some-
times bled after the injection and before I reached home, my uniform will be all soaked with blood. ‘‘
Side-effects mentioned ranged from very scary urine changes, rashes, dizziness to hearing
problems and loss of appetite. ‘‘after taken the drug your urine would change colour to red”
Most participants preferred the tablet. Only two participants reported to have problems with
the tablets. ‘For me, swallowing of the tablet or capsule was a problem to me, so I have to take it
with food or put it into rice ball before I can swallow it.”
Physiotherapy and POD. The discussion on the topics of physiotherapy and the preven-
tion of disability (POD) was mainly focused on the fact that though painful it was helpful to have
physiotherapy when they had the disease. ‘‘. . .and it was very painful, I always thought he was
very cruel, till it got healed without limitation that I realised that he was rather helping me.” Sug-
gestions for improving physiotherapy and POD focused on teaching the patients how to do it
themselves and training members of the community or family to assist. ‘‘I suggest there should be
certain people who would be from the community that would assist the victims in doing exercise‘‘.
Counselling. Overall, a large majority (71%) of the participants’ remarks indicated the
disease somehow socially and/or economically affected them. They either were unable to work
or got financial or family problems or they were stigmatized by their fellow villagers. So when
discussing the need for counselling, the participants in all groups agreed that more counselling
is necessary for various reasons. ‘‘I strongly support there is the need for counselling, because
when one gets the disease, you will realised family and friends begin to keep themselves away from
you and that alone make you feel sad.”
Vaccination. When asked about the possibility of getting a vaccination to prevent the dis-
ease, all participants fully agreed that that would be a very good idea and they fully supported
this idea. ‘‘I truly support participant nr. 7’s suggestion, because it is said that 'prevention is better
than cure'.” ‘‘I would be grateful to the Buruli ulcer team if they can get a vaccine for the disease”
Most important for future research. In the concluding question some focus went again
to the topic of vaccination, since that would prevent the disease. Another important topic men-
tioned was education on the disease and the importance of early recognition. Also a few men-
tioned that they thought research should focus on how the disease is transmitted, mainly
because then the disease might be preventable. ‘‘Again my concern is that we do not know how
one gets this disease, whether it is by, on or from the river. We cannot exactly feel how we get it,
but is just a presumption that we get it from the river and for that matter I will urge the govern-
ment to carry out a research on our river bodies and also get medicine that can eradicate this dis-
ease.” Changes in medication were also wanted, especially eliminating the injection from the
treatment regime and just supporting the medication and its availability in general. There
were also requests for more support for the victims of BU. ‘‘. . . because people of this village
called victims by the names “bankruptcy wound”.” Support for the doctors and nurses were also
mentioned as well as increasing the number of health workers. The accessibility of the health
services were also discussed, since the clinics were sometimes too far away to walk and not eas-
ily accessible by transport. ‘‘Other aspect that I think it should be improved, should be availability
of transportation for victims to easily reach their various hospital and clinic to seek treatment. My
saying this, because most of us find it very difficult to get access to vehicle to reach the hospital. ‘‘
And lastly it was also mentioned that the government could try to help out more in the rural
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areas and could try to protect people from getting the disease. ‘‘I would plead to the government
to reduce prices of farm protective clothing and shoes, so that farmers can afford them. Because
most of us work on our farms without these items and it has become very difficult for us to protect
ourselves from this disease, eventually coming home with this disease. Again if the government
can do their best to improve our sanitation situation in the village, because I think dirt also con-
tributes to the onset of the disease.”
Discussion
The study aimed to describe the experiences and needs of BU patients, to determine if former
BU patients have the same priorities as the current WHO research agenda and if this informa-
tion might benefit effective management and treatment of BU.
Experiences were elaborately described and very diverse. Several negative aspects of BU
management were identified. Many negative aspects were associated with pain, especially dur-
ing dressings, injections, and POD activities, which confirmed recent reports on pain being
common in BU [6, 30].
During the focus group discussions, in both areas, as well as between males and females,
hardly any discrepancies could be detected. Women were a little more elaborate on the social
consequences and the difficulties with accessing health care while men were slightly more focused
on preventative methods, like protective clothing. Negative experiences of treatment were mostly
associated with pain during dressings, physiotherapy or injections. This corresponds with the
findings of de Zeeuw et al. (2015) that pain management in BU needs more attention [30].
In addition, preventive measures and knowledge on transmission were frequently men-
tioned as points for improvement. Community based rehabilitation as suggested by the world
report on disability would be appreciated by and be beneficial to patients. Tuakli Wosorna and
Haig (2014) described that due to bidirectional social stigma these have not been very helpful
so far in Ghana [31]. Therefore it is important to encourage the empowerment and acceptation
of former patients. Furthermore, a high demand for support to deal with the economic and
social burden and need for counselling emerged from the focus group discussions.
The findings of the questionnaires showed that many participants appreciate the small
incentive they were given to come to the hospital. This confirms data from Ahorlu et al.
(2013), who found that social interventions, like free transportation and breakfast were benefi-
cial for early case detection and treatment, thus preventing further complications [32].
A noteworthy result is that former patients felt that they lacked information about the treat-
ment options and why the treatment would be carried out in a certain way. Uncertainty about
where to seek treatment and lack of knowledge about BU before they were diagnosed were
also mentioned. Indeed, early diagnosis and treatment is associated with better outcome
[13,14]. Several people in the focus group discussions mentioned that they were scared because
their urine changed colour during treatment, whilst this is invariably the case in individuals
taking rifampicin [33].
Limitations study
The questionnaires helped to identify topics for the focus groups discussion but were adminis-
trated two years earlier than the focus groups discussions. During this period patients’
experiences and opinions potentially could have changed. As BU treatment and manage-
ment did not change in these two years, we do not expect any impact on our results. Fur-
thermore, only former patients with small lesions (Category I or II) were included in the
study. Former patients or patients with larger lesions might have indicated other priorities.
Not all participants had BU in the same period, it might introduce recall bias. However,
Buruli Ulcer Patients’ Research Priorities
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005261 December 29, 2016 7 / 10
this recall problem could not be detected during the study and it was not mentioned by
participants.
In the overall results there was a lack of argumentation and support of statements made by
our study participants. This may be because participants are not aware of other possibilities to
do certain treatment aspects differently. Additionally, Ghana is known as a hierarchical culture
that is quite collectivist; ‘The doctor knows best’ [34]. This may have led participants to not
critically appraise their doctors and the treatment they received. Another reason might be that
the participants, though assured they should say anything they had on their mind, nonetheless
did not feel free to express all of their thoughts.
The participants of the focus group discussions easily reached agreement with limited dis-
cussions as a result, despite all focus groups consisting of a heterogeneous group and the facili-
tator stimulating discussion. Possible explanations can be that the former patients had similar
experiences concerning treatment or that a negative group dynamic occurred. However, dur-
ing the discussion all were encouraged equally to express their opinion. During the discussion
equal opportunities for expression were monitored and all participants were involved in order
to minimize effects of group dynamics. We therefore conclude that limitations due to negative
group dynamics were minimal.
Members of the local BU team were working on the study; this might have affected the par-
ticipants’ sense of freedom of expression, though all members not vital for the discussion were
asked to leave the area where the groups met. To promote participants to express their opin-
ions a former BU patient was designated as moderator. By inviting a former BU patient, and
not a staff member, we aimed that participants would feel more comfortable during the discus-
sion, knowing that the moderator could identify with them, and encourage the discussion
effectively.
Conclusion
The preferences and priorities of BU patients appeared generally in agreement with the inter-
national research agenda. Additional preventive measures, accessibility and pain were men-
tioned as important subjects. More counselling would benefit some patients, since the disease
may have a huge impact on life, economically as well as socially. Community based rehabilita-
tion was suggested, thus enlarging the public support for the disease as well as benefitting the
patients directly. In addition, for clinical purposes, more explanation on the course of treat-
ment and expected side effects appears necessary, since a lack of knowledge on these aspects
was indicated. Doctors are limited in their time to explain issues extensively, but giving more
elaborate information on the management of the disease and possible side-effects appears to
be useful to enhance compliance to treatment.
This information could aid in creating a patient based BU research agenda in which patient
empowerment in neglected tropical diseases may improve healthcare.
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(PDF)
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